4 assets in Choriocarcinoma Of Ovary

Therapeutic assets addressing Choriocarcinoma Of Ovary, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Carboplatin Choriocarcinoma Of Ovary	Children's Oncology Group	P3	BB (66)
Bleomycin Choriocarcinoma Of Ovary	Children's Oncology Group	P3	B (60)
Cis-Diamminedichloroplatinum Ii Choriocarcinoma Of Ovary	Children's Oncology Group	P3	B (60)
Etoposide Choriocarcinoma Of Ovary	Children's Oncology Group	P3	B (60)